Mingchuan Zhao

1.3k total citations
28 papers, 1.1k citations indexed

About

Mingchuan Zhao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mingchuan Zhao has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Mingchuan Zhao's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Treatment and Pharmacology (5 papers). Mingchuan Zhao is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Treatment and Pharmacology (5 papers). Mingchuan Zhao collaborates with scholars based in China and United States. Mingchuan Zhao's co-authors include Huijun Zhang, Yishi Zhang, Chao Zhao, Xuefei Li, Ningning Cheng, Shengxiang Ren, Heyong Wang, Gentao Liu, Weijing Cai and Liang Tang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mingchuan Zhao

23 papers receiving 1.1k citations

Peers

Countries citing papers authored by Mingchuan Zhao

Since Specialization

Citations

This map shows the geographic impact of Mingchuan Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingchuan Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingchuan Zhao more than expected).

Fields of papers citing papers by Mingchuan Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingchuan Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingchuan Zhao. The network helps show where Mingchuan Zhao may publish in the future.

Co-authorship network of co-authors of Mingchuan Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Mingchuan Zhao. A scholar is included among the top collaborators of Mingchuan Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingchuan Zhao. Mingchuan Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and genomic characteristics of HER2-ultralow breast cancer and implications for T-DXd therapy 2025 ·Precision Clinical Medicine ·Juan Jin, Tiantian Liu, (unknown), Mingchuan Zhao, (unknown), (unknown), Leiping Wang, Biyun Wang, Hongxia Wang, Zhonghua Tao, Wentao Yang, Xichun Hu	0
2	MYC amplification sensitizes TNBC to CHK1 inhibitors 2025 ·Cellular Signalling ·Bin Li, Tiantian Liu, Mingchuan Zhao, (unknown), Wenxia Peng, Zhonghua Tao, (unknown), Juan Jin	0
3	Abstract PO2-06-11: A phase II randomized trial of gemcitabine plus cisplatin(GP) vs gemcitabine plus carboplatin (GC) as the first-line treatment for patients with metastatic triple-negative breast cancer 2024 ·Cancer Research ·Chengcheng Gong, Yannan Zhao, Leiping Wang, Jun Cao, Zhonghua Tao, (unknown), Mingchuan Zhao, (unknown), (unknown), Xichun Hu, Biyun Wang	0
4	A phase II trial combining SHR-1316, bevacizumab, and cisplatin/carboplatin in patients with TNBC with active brain metastases. 2024 ·Journal of Clinical Oncology ·Ting Li, Mingchuan Zhao, Jun Cao, Jianfei Wang, Zhonghua Tao, Biyun Wang, Xichun Hu, Jian Zhang	3
5	Safety and preliminary efficacy of GQ1001, a next generation HER2-targeting ADC, combined with pyrotinib in pretreated patients with HER2-positive metastatic breast cancer: A phase 1b clinical trial. 2024 ·Journal of Clinical Oncology ·Biyun Wang, Chengcheng Gong, Leiping Wang, Xichun Hu, Ting Li, Zhonghua Tao, Mingchuan Zhao, Yannan Zhao	0
6	Analysis of clinical features, genomic landscapes and survival outcomes in HER2-low breast cancer 2023 ·Journal of Translational Medicine ·Juan Jin, Bin Li, (unknown), Ting Li, Jian Zhang, Jun Cao, Mingchuan Zhao, Leiping Wang, Biyun Wang, Zhonghua Tao, Xichun Hu	18
7	EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism 2018 ·Lung Cancer ·(unknown), Yayi He, Tao Jiang, Shengxiang Ren, Fei Zhou, Chao Zhao, Xuefei Li, Jie Zhang, Chunxia Su, Xiaoxia Chen, Weijing Cai, Guanghui Gao, Wěi Li, Fengying Wu, Jiayu Li, Jing Zhao, Qiong Hu, Mingchuan Zhao, (unknown), Fred R. Hirsch	9
8	Serum Levels of the Cancer-Testis Antigen POTEE and Its Clinical Significance in Non-Small-Cell Lung Cancer 2015 ·PLoS ONE ·Qi Wang, Xuefei Li, Shengxiang Ren, Ningning Cheng, Mingchuan Zhao, Yishi Zhang, Jiayu Li, Weijing Cai, Chao Zhao, (unknown), Caicun Zhou	16
9	Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small cell lung cancer. 2015 ·Journal of Clinical Oncology ·Qi Wang, Xuefei Li, Shengxiang Ren, Ningning Cheng, Weijing Cai, Chao Zhao, Mingchuan Zhao, Jiayu Li, Caicun Zhou	2
10	Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma 2014 ·Lung Cancer ·Mingchuan Zhao, Yishi Zhang, Huijun Zhang, Shaohua Wang, Mengmeng Zhang, Xi Chen, (unknown), Gang Zeng, Xiaofeng Chen, Gentao Liu, Caicun Zhou	55
11	Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients 2014 ·Translational Oncology ·Xuefei Li, (unknown), Shengxiang Ren, Xiaoxia Chen, Weijing Cai, Fei Zhou, Yishi Zhang, Chunxia Su, Chao Zhao, Jiayu Li, Ningning Cheng, Mingchuan Zhao, Caicun Zhou	64
12	The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non–small cell lung cancer 2014 ·Cancer ·Mingchuan Zhao, Yishi Zhang, Weijing Cai, Jiayu Li, Fei Zhou, Ningning Cheng, (unknown), Chao Zhao, Xuefei Li, Shengxiang Ren, Caicun Zhou, Fred R. Hirsch	77
13	Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancer 2014 ·Oncology Reports ·Ningning Cheng, Xuefei Li, Chao Zhao, Shengxiang Ren, Xiaoxia Chen, Weijing Cai, Mingchuan Zhao, Yishi Zhang, Jiayu Li, Qi Wang, Caicun Zhou	79
14	miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin β1 and Matrix Metalloproteinase2 (MMP2) 2013 ·PLoS ONE ·Heyong Wang, Yingchao Zhu, Mingchuan Zhao, Chunlian Wu, Peng Zhang, Liang Tang, Huijun Zhang, Xiaofeng Chen, Yaoqin Yang, Gentao Liu	109
15	Feasibility and long-term efficacy of video-assisted thoracic surgery for unexpected pathologic N2 disease in non-small cell lung cancer 2013 ·Annals of Thoracic Medicine ·Xiaofeng Chen, (unknown), Wenyong Zhou, (unknown), Mingchuan Zhao	5
16	MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer 2013 ·Cellular Physiology and Biochemistry ·(unknown), Hui Zhang, Mingchuan Zhao, Zhongwei Lv, Xiaoping Zhang, Xiong Qin, Heyong Wang, Shaohua Wang, Jinmei Su, Xin Lv, (unknown), Weijia Du, Wenyong Zhou, Xiaofeng Chen, Fei Ke	113
17	Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis 2012 ·Toxicology ·Heyong Wang, Huijun Zhang, Liang Tang, Hạixia Chen, Chunlian Wu, Mingchuan Zhao, Yaoqin Yang, Xiaofeng Chen, Gentao Liu	136
18	Video‐assisted thoracic surgery lobectomy for unexpected pathologic N2 non‐small cell lung cancer 2012 ·Thoracic Cancer ·(unknown), Xiaofeng Chen, Huijun Zhang, Hui Zhang, Mingchuan Zhao	7
19	Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition 2011 ·Molecular and Cellular Biochemistry ·Huijun Zhang, Heyong Wang, Hongtao Zhang, Jinmei Su, Jun Zhu, Haibing Wang, Wenyong Zhou, Hui Zhang, Mingchuan Zhao, Lei Zhang, Xiaofeng Chen	71
20	Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways 2011 ·Molecular Biology Reports ·Xiaofeng Chen, Huijun Zhang, Haibing Wang, Jun Zhu, Wenyong Zhou, Hui Zhang, Mingchuan Zhao, Jinmei Su, Wen Gao, Lei Zhang, Ke Fei, Hongtao Zhang, Heyong Wang	111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact